Endpoints News 生物医药· Max Bayer·· 10 天前AI 评分50
FDA 要求 GLP-1 药企更新说明书,提醒罕见眼病风险
FDA orders GLP-1 drugmakers to warn of rare eye disease
AI 导读
FDA 要求 GLP-1 药企更新说明书,提醒罕见眼病风险,可能影响同类产品的监管要求。
正文
The FDA told GLP-1 drugmakers to update their product labels to reflect an increased risk of a rare eye condition that could lead to blindness.
…
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news